ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 41.89.
| Share Price | ₹29,818.8 | Dec 01,2025 |
| Market Cap | ₹63,215.9 Cr | |
| Earnings-TTM | ₹1,509.0 Cr | TTM-Standalone Results |
| Price/Earnings | 41.89x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹63,215.9 Cr] as on Dec 01,2025
(/) Earnings [ ₹1,509.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 41.89x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 41.89 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 47.29x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2023 at 49.43x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 46.11x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ABBOTT INDIA | 1,508.95 | 41.89 | 63,215.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 41.24 | 433,764.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.61 | 170,489.0 |
| CIPLA LTD | 5,453.86 | 22.57 | 123,088.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 59.09 | 126,442.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.38 | 105,162.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.09 | 92,051.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.95 | 94,223.8 |
| LUPIN LTD | 4,347.53 | 21.92 | 95,296.6 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.47 | 70,579.0 |
| ALKEM LABORATORIES LTD | 2,411.72 | 27.79 | 67,016.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.38x |
| Max industry PE | 68.61x |
| Median industry PE | 27.79x |
| Average industry PE | 35.73x |
You may also like the below Video Courses